• Clinical Evidence

Comparison of a Computer-Based Intravenous Insulin Program with a Standard Paper Protocol in Terms of Safety and Efficacy in Management of DKA Patients in Community Hospitals: A Pilot Study

Setting: Cohort of six community hospitals.

Objective

This retrospective analysis compares safety and efficacy of a standard paper protocol to a computer-based glucose management system (EndoTool) for patients admitted with diabetic ketoacidosis (DKA).

Setting

Cohort of six community hospitals.

Results

  • Mean time to a blood glucose <200 mg/dL was 287 minutes with EndoTool versus 336 minutes with a paper protocol.
  • Incidence of hypoglycemia was 0.00% of patients with EndoTool versus 10.0% of patients with a paper protocol.
  • Mean number of finger stick blood glucose readings per hour was 0.91 with EndoTool versus 0.99 with a paper protocol.
  • Nursing adherence to dosing recommendations was 100% with EndoTool versus 37% with a paper protocol.

Conclusions

With faster time to control, lower incidence of hypoglycemia and fewer finger sticks, a computer-based glucose management system (EndoTool) provides a safer, more simplified approach to intravenous insulin therapy than a paper protocol for patients admitted with DKA.
Objective

This retrospective analysis compares safety and efficacy of a standard paper protocol to a computer-based glucose management system (EndoTool) for patients admitted with diabetic ketoacidosis (DKA).

Setting

Cohort of six community hospitals.

Results
  • Mean time to a blood glucose <200 mg/dL was 287 minutes with EndoTool versus 336 minutes with a paper protocol.
  • Incidence of hypoglycemia was 0.00% of patients with EndoTool versus 10.0% of patients with a paper protocol.
  • Mean number of finger stick blood glucose readings per hour was 0.91 with EndoTool versus 0.99 with a paper protocol.
  • Nursing adherence to dosing recommendations was 100% with EndoTool versus 37% with a paper protocol.
Conclusions

With faster time to control, lower incidence of hypoglycemia and fewer finger sticks, a computer-based glucose management system (EndoTool) provides a safer, more simplified approach to intravenous insulin therapy than a paper protocol for patients admitted with DKA.

References

Authors

M. Raihan Azad; Sandra Hardee; Su-Fan Vanessa Lin; Robert Tanenberg.

Source

Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.

Year

2017

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective analysis compares safety and efficacy of a standard paper protocol to a computer-based glucose management system (EndoTool) for patients admitted with diabetic ketoacidosis (DKA).

Setting

Cohort of six community hospitals.

Results
  • Mean time to a blood glucose <200 mg/dL was 287 minutes with EndoTool versus 336 minutes with a paper protocol.
  • Incidence of hypoglycemia was 0.00% of patients with EndoTool versus 10.0% of patients with a paper protocol.
  • Mean number of finger stick blood glucose readings per hour was 0.91 with EndoTool versus 0.99 with a paper protocol.
  • Nursing adherence to dosing recommendations was 100% with EndoTool versus 37% with a paper protocol.
Conclusions

With faster time to control, lower incidence of hypoglycemia and fewer finger sticks, a computer-based glucose management system (EndoTool) provides a safer, more simplified approach to intravenous insulin therapy than a paper protocol for patients admitted with DKA.

References

Authors

M. Raihan Azad; Sandra Hardee; Su-Fan Vanessa Lin; Robert Tanenberg.

Source

Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.

Year

2017

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.